Good news about a bad subject: scientific evidence to help defeat multidrug/extensively drug-resistant tuberculosis

Sotgiu Giovanni, Woodhead Mark

Source: Eur Respir J 2014; 44: 5-7
Journal Issue: July
Disease area: Respiratory infections

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sotgiu Giovanni, Woodhead Mark. Good news about a bad subject: scientific evidence to help defeat multidrug/extensively drug-resistant tuberculosis. Eur Respir J 2014; 44: 5-7

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis
Source: ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020
Year: 2020



What do scientists and doctors want from media coverage? How can patient input strengthen a news story?
Source: Annual Congress 2013 –ELF/ERS “Effective engagement of patients and the public in science, healthcare and the media”
Year: 2013

TB "cross-border" - a new challenge in tuberculosis management
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020


WHO 2019 guidelines on drug-resistant tuberculosis treatment: based on evidence or expert opinion?
Source: Eur Respir J, 55 (3) 1901935; 10.1183/13993003.01935-2019
Year: 2020



Behaviour change and communication in pandemics: key elements in breaking bad news
Source: International Congress 2015 – Pandemics and emerging infections
Year: 2015

TB disease and infection. Do we have real news?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


Ripped from the headlines: how can we harness communications to control TB?
Source: Eur Respir J 2007; 30: 194-198
Year: 2007


Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly
Source: Eur Respir J 2016; 48: 1800-1802
Year: 2016


When and how to communicate bad news to our patients
Source: International Congress 2016 – When respiratory disease come to an end
Year: 2016


Communication of bad news: do regional differences exist in Europe and around the world?
Source: ERS Online Course 2016
Year: 2016

Equivocal diagnoses - handling uncertainty when breaking bad news
Source: International Congress 2015 – Deliver bad news
Year: 2015



Getting the word out: how to talk to the public about your research
Source: Breathe, 16 (2) 200008; 10.1183/20734735.0008-2020
Year: 2020



Is the current publishing and funding environment ruining our research?
Source: International Congress 2015 – Acute lung injury research: are we doing the right things?
Year: 2015



"Don’t get me wrong, I think case finding is okay" Exploring healthcare professionals’ perspectives on target case-finding for COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Managing difficult TB cases: experiences from the ERS/WHO TB Consilium and other country-specific Consilia
Source: International Congress 2017 – In the frontline of the fight against tuberculosis
Year: 2017


Closing the gap in surveillance of tuberculosis and HIV co-infection: a European perspective on the need for clinician–public health alliances
Source: Eur Respir J, 50 (5) 1701758; 10.1183/13993003.01758-2017
Year: 2017



Evidence-based, agreed-upon health priorities to remedy the tuberculosis patient's economic disaster
Source: Eur Respir J 2014; 43: 1563-1566
Year: 2014


Is there enough evidence to support recommendations on tuberculosis control?
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008